News
Here's why you should take advantage. Dr. Reddy's, Sandoz and Teva Pharmaceuticals have been highlighted in this Industry Outlook article. Despite the impact of dynamic shifts in the regulatory ...
We will work closely with Teva to ensure access of this medicine for payers, healthcare professionals and patients in the U.S.,” she added.
The management of Israeli pharma group Teva has laid out its strategy for a return to growth after a challenging few years, with a greater emphasis on innovative medicines and a focus on complex ...
February 21, 2025 Teva Pharma and Alvotech launch biosimilar to J&J's Stelara in US Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's ...
Teva Pharmaceutical Industries Ltd is a global leader in the pharmaceutical industry, specializing in the development, manufacture, and distribution of generic and specialty medicines, as well as ...
As mentioned, the likes of Teva, Sun Pharma, Dr Reddy's, Cipla, Gland Pharma, Aurobindo Pharmaceuticals, Lupin, Biocon, and Glenmark Pharmaceuticals would surely see their business hit hard by ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
is due to take the top job at Teva on 1 January, and will serve as the pharma company's president. He is currently also a partner at UK investment group Syncona, which holds stakes in both ...
At the Standalone during the January to March 2025 quarter, the Sudarshan Pharma Industries net profit at ₹9.95 crore also saw a sharp rise The net profit for the quarter reported buy the ...
Indian pharma stocks, including Sun Pharmaceutical Industries, Gland Pharma, Lupin and others traded sharply lower on Wednesday after the US President Donald Trump said he will soon announce a ...
Soliris® (eculizumab), making it one of the greatest cost-saving biosimilars to Soliris® in the U.S. Teva and Samsung Bioepis entered into a strategic partnership in January 2025 for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results